ArticleSurgery today2017

Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma.

Hidetoshi Nitta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.